Dyne Therapeutics, Inc. (DYN) DCF Valuation

Dyne Therapeutics, Inc. (DYN) DCF Valoración

US | Healthcare | Biotechnology | NASDAQ
Dyne Therapeutics, Inc. (DYN) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

Dyne Therapeutics, Inc. (DYN) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

¡Mejore sus estrategias de inversión con la calculadora DCF de Dyne Therapeutics, Inc. (DYN)! Revise los últimos datos financieros, ajuste las proyecciones y gastos de crecimiento, y observe instantáneamente cómo estas modificaciones afectan el valor intrínseco de Dyne Therapeutics, Inc. (DYN).


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -14.6 -58.3 -148.2 -164.8 -233.5 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation .3 .7 1.1 3.3 2.5 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -14.9 -59.0 -149.3 -168.1 -235.9 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash 14.6 345.3 376.6 256.0 123.1 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .0
Account Receivables, % 100 100 100 100 100
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable 1.3 3.4 4.0 5.3 22.9 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure -1.6 -1.2 -3.6 -3.1 -.7 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -13.5 -58.3 -149.3 -165.2 -235.9 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -13.7 -56.6 -151.2 -163.7 -216.5 -22.9 .0 .0 .0 .0
WACC, % 9.51 9.52 9.52 9.52 9.52 9.52 9.52 9.52 9.52 9.52
PV UFCF
SUM PV UFCF -20.9
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -21
Net Debt -94
Equity Value 73
Diluted Shares Outstanding, MM 60
Equity Value Per Share 1.23

What You Will Get

  • Real DYN Financials: Access to both historical and projected data for precise valuation.
  • Customizable Inputs: Adjust WACC, tax rates, revenue growth, and capital expenditures to fit your analysis.
  • Dynamic Calculations: Intrinsic value and NPV are computed automatically in real-time.
  • Scenario Analysis: Evaluate various scenarios to assess Dyne Therapeutics' future performance.
  • User-Friendly Design: Designed for professionals while remaining accessible to newcomers.

Key Features

  • Customizable Research Parameters: Adjust essential inputs such as clinical trial success rates, revenue forecasts, and R&D expenditures.
  • Instant Valuation Insights: Automatically computes intrinsic value, NPV, and other financial metrics in real-time.
  • High-Precision Analytics: Leverages Dyne Therapeutics’ actual financial data for accurate valuation results.
  • Streamlined Scenario Testing: Easily explore various assumptions and evaluate different outcomes.
  • Efficiency Booster: Remove the hassle of constructing intricate valuation models from the ground up.

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review pre-entered Dyne Therapeutics data (historical and projected).
  3. Step 3: Adjust key assumptions (yellow cells) based on your analysis.
  4. Step 4: View automatic recalculations for Dyne Therapeutics’ intrinsic value.
  5. Step 5: Use the outputs for investment decisions or reporting.

Why Choose This Calculator for Dyne Therapeutics, Inc. (DYN)?

  • Accurate Data: Utilize real Dyne Therapeutics financial data for dependable valuation outcomes.
  • Customizable: Tailor essential parameters such as growth projections, WACC, and tax rates to fit your specific needs.
  • Time-Saving: Pre-configured calculations save you the effort of starting from the ground up.
  • Professional-Grade Tool: Crafted for investors, analysts, and consultants in the biotech sector.
  • User-Friendly: Simple design and clear step-by-step guidance make it accessible for everyone.

Who Should Use Dyne Therapeutics, Inc. (DYN)?

  • Individual Investors: Gain insights to make informed decisions about investing in Dyne Therapeutics.
  • Financial Analysts: Enhance your analysis with comprehensive financial models tailored for Dyne Therapeutics.
  • Consultants: Provide clients with expert valuation insights related to Dyne Therapeutics efficiently and effectively.
  • Business Owners: Learn from Dyne Therapeutics' valuation to inform your own business strategies.
  • Finance Students: Explore valuation methodologies using real data from Dyne Therapeutics for practical learning.

What the Template Contains

  • Pre-Filled DCF Model: Dyne Therapeutics, Inc. (DYN)’s financial data preloaded for immediate use.
  • WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
  • Financial Ratios: Evaluate Dyne Therapeutics, Inc. (DYN)’s profitability, leverage, and efficiency.
  • Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
  • Financial Statements: Annual and quarterly reports to support detailed analysis.
  • Interactive Dashboard: Easily visualize key valuation metrics and results.

No products were found matching.